UK markets closed
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • FTSE 250

    22,948.83
    -101.63 (-0.44%)
     
  • AIM

    1,251.11
    +3.84 (+0.31%)
     
  • GBP/EUR

    1.1713
    -0.0024 (-0.20%)
     
  • GBP/USD

    1.3908
    -0.0050 (-0.35%)
     
  • BTC-GBP

    30,184.63
    -67.93 (-0.22%)
     
  • CMC Crypto 200

    955.03
    +5.13 (+0.54%)
     
  • S&P 500

    4,395.26
    -23.89 (-0.54%)
     
  • DOW

    34,935.47
    -149.06 (-0.42%)
     
  • CRUDE OIL

    73.81
    +0.19 (+0.26%)
     
  • GOLD FUTURES

    1,812.50
    -18.70 (-1.02%)
     
  • NIKKEI 225

    27,283.59
    -498.83 (-1.80%)
     
  • HANG SENG

    25,961.03
    -354.29 (-1.35%)
     
  • DAX

    15,544.39
    -96.08 (-0.61%)
     
  • CAC 40

    6,612.76
    -21.01 (-0.32%)
     

Global Lateral Flow Assays Market to Reach US$11.6 Billion by the Year 2027

·23-min read

Abstract: - Global Lateral Flow Assays Market to Reach US$11. 6 Billion by the Year 2027. - Amid the COVID-19 crisis, the global market for Lateral Flow Assays estimated at US$7.

New York, June 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Lateral Flow Assays Industry" - https://www.reportlinker.com/p06097736/?utm_source=GNW
8 Billion in the year 2020, is projected to reach a revised size of US$11.6 Billion by 2027, growing at a CAGR of 5.9% over the period 2020-2027.Kits & Reagents, one of the segments analyzed in the report, is projected to grow at a 6.1% CAGR to reach US$9.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lateral Flow Readers segment is readjusted to a revised 4.9% CAGR for the next 7-year period. This segment currently accounts for a 17.9% share of the global Lateral Flow Assays market.

- The U.S. Accounts for Over 38.6% of Global Market Size in 2020, While China is Forecast to Grow at a 8.8% CAGR for the Period of 2020-2027

- The Lateral Flow Assays market in the U.S. is estimated at US$3 Billion in the year 2020. The country currently accounts for a 38.64% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$917 Million in the year 2027 trailing a CAGR of 8.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR while Rest of European market (as defined in the study) will reach US$917 Million by the year 2027.

- Select Competitors (Total 55 Featured)

  • Abbott Laboratories, Inc.

  • Alere, Inc.

  • Becton, Dickinson and Company

  • bioMerieux SA

  • Bio-Rad Laboratories, Inc.

  • Danaher Corporation

  • F. Hoffmann-La Roche AG

  • Hologic, Inc.

  • Johnson & Johnson

  • PerkinElmer, Inc.

  • Qiagen NV

  • Quidel Corporation

  • Siemens AG

  • Thermo Fisher Scientific, Inc.




Read the full report: https://www.reportlinker.com/p06097736/?utm_source=GNW

CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
Challenges and Opportunities for Clinical Diagnostics amid the
Pandemic
Impact of COVID-19 on Lateral Flow Assays Market
Performance Analysis of COVID-19 Tests
EXHIBIT 2: COVID-19 Cases Worldwide by Country: As on May 17, 2021
Lateral Flow Assay-based Tests Soar into Spotlight during
COVID-19 Pandemic
LFAS Arms Nations to Battle the Coronavirus
GLOBAL MARKET OVERVIEW
A Prelude to Lateral Flow Technology
Lateral Flow Assays: An Introduction
Lateral Flow Assays: A Mighty, Paper-based Diagnostics Approach
Lateral Flow Assays Market Poised to Experience Uninterrupted
Flow Ahead
Clinical Testing Remains Primary Application Segment of Lateral
Flow Assays Market
Rising Incidence of Infectious Conditions Ignite Demand
LFA Overcomes Testing Barriers
The US Retains Leadership Tag in Global Lateral Flow Assays Market
Fast Paced Growth Projected in Developing Regions
Market Outlook
Competitive Scenario
RECENT MARKET ACTIVITY

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Growing Incidence of Infectious Diseases to Drive LFA Market
EXHIBIT 3: Infectious Diseases Remain Major Cause of Death in
Under Developed Regions: Breakdown of Leading Causes of Death
in Sub-Saharan Africa (in %)
EXHIBIT 4: Global Malaria Case Incidence Rate (per 1,000
population) for the Years 2015, 2016, 2017 & 2018
EXHIBIT 5: Global TB Cases (In Millions) Reported to Have Been
Treated for the Years 2015-2019
Greater Number of Tests for HIV and Sexually Transmitted
Diseases Amplify Growth
EXHIBIT 6: Global HIV Prevalence: Number of People Living with
AIDs (in Thousands) by Region for 2018
EXHIBIT 7: Number of AIDS-Related Deaths (in Thousands) by
Region for 2018
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer
Disease
Home HIV Testing Emerges as a Lucrative Option
Viral Hepatitis Testing Presents Opportunities for Lateral Flow
Assays Market
EXHIBIT 8: Hepatitis B prevalence Worldwide by Region
Uptrend in Healthcare Spending Creates Fertile Environment
EXHIBIT 9: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
EXHIBIT 10: Healthcare Costs as a % of GDP by Country for the
Years 2020 & 2023
Ageing Demographics to Drive Demand
EXHIBIT 11: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050
EXHIBIT 12: Elderly Population (65+ Years) as a % of Total
Population by Developed, Less Developed and Least Developed
Regions: 2019 & 2030
Self-Diagnosis Emerges as a Notable Trend
New Approvals of Self-Test Devices to Give a Boost to the Market
Lateral Flow Assays Hold Rosy Outlook with Emerging
Applications Areas
LFAs Gains Foothold in Multiplexing
Multiplexed Point-Of-Care Testing
Remote Healthcare Benefits Lateral Flow Assays Market
Lateral Flow Assays to Become Landmark Approach in Precision
Diagnostics
Lateral Flow Assays & Precision Diagnostics
Digitalization of Lateral Flows to Support Healthcare
Digitalized Lateral Flow Assays: An Exciting Platform to Change
Data-Driven Healthcare Domain
Lateral Flow Assays Emerge as Integral Components of Food
Safety & Environmental Testing
Novel Lateral Flow Assay Marks Shift from Reactive to Proactive
Food Safety Testing Approach
Technological Advancements Remain Crucial to Future Growth
Researchers Develop Novel Technique to Significantly Increase
Accuracy of Lateral Flow Tests
Smartphone-based Fully-Quantitative Lateral Flow Assay Analyzer
for Reliable & Quick Diagnosis
Innovative Lateral Flow Immunoassays Find Increasing Role in
Detection of Dengue & Zika Virus
Abingdon Health Introduced ADxLR5® Developer for Assay Development
Rapid Tests Connectivity with Wireless Data Platforms
Miniaturization of Analytical Instruments Presents Lucrative
Opportunities for Handheld Lateral Flow Assay Readers
Low Accuracy Remains a Major Restraint
Limited Reimbursement & Raw Material Supply Issues as Key
Challenges

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Lateral Flow
Assays by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Lateral Flow Assays by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Lateral Flow Assays by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Kits & Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Kits & Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Kits & Reagents by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Lateral Flow
Readers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Lateral Flow Readers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Lateral Flow Readers by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Clinical Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Clinical Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Clinical Testing by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Veterinary
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Veterinary Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Veterinary Diagnostics
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Diagnostic
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Diagnostic Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Diagnostic Laboratories
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Pharma & Biotech
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Pharma & Biotech Companies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 28: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 31: USA Current & Future Analysis for Lateral Flow Assays
by Product - Kits & Reagents and Lateral Flow Readers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Lateral Flow Assays by
Product - Kits & Reagents and Lateral Flow Readers Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Lateral Flow Assays by
Product - Percentage Breakdown of Value Revenues for Kits &
Reagents and Lateral Flow Readers for the Years 2012, 2020 &
2027

Table 34: USA Current & Future Analysis for Lateral Flow Assays
by Application - Clinical Testing, Veterinary Diagnostics and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Lateral Flow Assays by
Application - Clinical Testing, Veterinary Diagnostics and
Other Applications Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Lateral Flow Assays by
Application - Percentage Breakdown of Value Revenues for
Clinical Testing, Veterinary Diagnostics and Other Applications
for the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Lateral Flow Assays
by End-Use - Hospitals & Clinics, Diagnostic Laboratories,
Pharma & Biotech Companies and Other End-Uses - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 38: USA Historic Review for Lateral Flow Assays by
End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Lateral Flow Assays by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Diagnostic Laboratories, Pharma & Biotech Companies
and Other End-Uses for the Years 2012, 2020 & 2027

CANADA
Table 40: Canada Current & Future Analysis for Lateral Flow
Assays by Product - Kits & Reagents and Lateral Flow Readers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Lateral Flow Assays by
Product - Kits & Reagents and Lateral Flow Readers Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Lateral Flow Assays by
Product - Percentage Breakdown of Value Revenues for Kits &
Reagents and Lateral Flow Readers for the Years 2012, 2020 &
2027

Table 43: Canada Current & Future Analysis for Lateral Flow
Assays by Application - Clinical Testing, Veterinary
Diagnostics and Other Applications - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 44: Canada Historic Review for Lateral Flow Assays by
Application - Clinical Testing, Veterinary Diagnostics and
Other Applications Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Lateral Flow Assays by
Application - Percentage Breakdown of Value Revenues for
Clinical Testing, Veterinary Diagnostics and Other Applications
for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Lateral Flow
Assays by End-Use - Hospitals & Clinics, Diagnostic
Laboratories, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Lateral Flow Assays by
End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Lateral Flow Assays by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Diagnostic Laboratories, Pharma & Biotech Companies
and Other End-Uses for the Years 2012, 2020 & 2027

JAPAN
Table 49: Japan Current & Future Analysis for Lateral Flow
Assays by Product - Kits & Reagents and Lateral Flow Readers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Lateral Flow Assays by
Product - Kits & Reagents and Lateral Flow Readers Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Lateral Flow Assays by
Product - Percentage Breakdown of Value Revenues for Kits &
Reagents and Lateral Flow Readers for the Years 2012, 2020 &
2027

Table 52: Japan Current & Future Analysis for Lateral Flow
Assays by Application - Clinical Testing, Veterinary
Diagnostics and Other Applications - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 53: Japan Historic Review for Lateral Flow Assays by
Application - Clinical Testing, Veterinary Diagnostics and
Other Applications Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Lateral Flow Assays by
Application - Percentage Breakdown of Value Revenues for
Clinical Testing, Veterinary Diagnostics and Other Applications
for the Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Lateral Flow
Assays by End-Use - Hospitals & Clinics, Diagnostic
Laboratories, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Lateral Flow Assays by
End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Lateral Flow Assays by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Diagnostic Laboratories, Pharma & Biotech Companies
and Other End-Uses for the Years 2012, 2020 & 2027

CHINA
Table 58: China Current & Future Analysis for Lateral Flow
Assays by Product - Kits & Reagents and Lateral Flow Readers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Lateral Flow Assays by
Product - Kits & Reagents and Lateral Flow Readers Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Lateral Flow Assays by
Product - Percentage Breakdown of Value Revenues for Kits &
Reagents and Lateral Flow Readers for the Years 2012, 2020 &
2027

Table 61: China Current & Future Analysis for Lateral Flow
Assays by Application - Clinical Testing, Veterinary
Diagnostics and Other Applications - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 62: China Historic Review for Lateral Flow Assays by
Application - Clinical Testing, Veterinary Diagnostics and
Other Applications Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Lateral Flow Assays by
Application - Percentage Breakdown of Value Revenues for
Clinical Testing, Veterinary Diagnostics and Other Applications
for the Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Lateral Flow
Assays by End-Use - Hospitals & Clinics, Diagnostic
Laboratories, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Lateral Flow Assays by
End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 66: China 15-Year Perspective for Lateral Flow Assays by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Diagnostic Laboratories, Pharma & Biotech Companies
and Other End-Uses for the Years 2012, 2020 & 2027

EUROPE
Table 67: Europe Current & Future Analysis for Lateral Flow
Assays by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 68: Europe Historic Review for Lateral Flow Assays by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Lateral Flow Assays by
Geographic Region - Percentage Breakdown of Value Revenues for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Lateral Flow
Assays by Product - Kits & Reagents and Lateral Flow Readers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Lateral Flow Assays by
Product - Kits & Reagents and Lateral Flow Readers Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Lateral Flow Assays by
Product - Percentage Breakdown of Value Revenues for Kits &
Reagents and Lateral Flow Readers for the Years 2012, 2020 &
2027

Table 73: Europe Current & Future Analysis for Lateral Flow
Assays by Application - Clinical Testing, Veterinary
Diagnostics and Other Applications - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 74: Europe Historic Review for Lateral Flow Assays by
Application - Clinical Testing, Veterinary Diagnostics and
Other Applications Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Lateral Flow Assays by
Application - Percentage Breakdown of Value Revenues for
Clinical Testing, Veterinary Diagnostics and Other Applications
for the Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Lateral Flow
Assays by End-Use - Hospitals & Clinics, Diagnostic
Laboratories, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Lateral Flow Assays by
End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Lateral Flow Assays by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Diagnostic Laboratories, Pharma & Biotech Companies
and Other End-Uses for the Years 2012, 2020 & 2027

FRANCE
Table 79: France Current & Future Analysis for Lateral Flow
Assays by Product - Kits & Reagents and Lateral Flow Readers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Lateral Flow Assays by
Product - Kits & Reagents and Lateral Flow Readers Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Lateral Flow Assays by
Product - Percentage Breakdown of Value Revenues for Kits &
Reagents and Lateral Flow Readers for the Years 2012, 2020 &
2027

Table 82: France Current & Future Analysis for Lateral Flow
Assays by Application - Clinical Testing, Veterinary
Diagnostics and Other Applications - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 83: France Historic Review for Lateral Flow Assays by
Application - Clinical Testing, Veterinary Diagnostics and
Other Applications Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Lateral Flow Assays by
Application - Percentage Breakdown of Value Revenues for
Clinical Testing, Veterinary Diagnostics and Other Applications
for the Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Lateral Flow
Assays by End-Use - Hospitals & Clinics, Diagnostic
Laboratories, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Lateral Flow Assays by
End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 87: France 15-Year Perspective for Lateral Flow Assays by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Diagnostic Laboratories, Pharma & Biotech Companies
and Other End-Uses for the Years 2012, 2020 & 2027

GERMANY
Table 88: Germany Current & Future Analysis for Lateral Flow
Assays by Product - Kits & Reagents and Lateral Flow Readers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Lateral Flow Assays by
Product - Kits & Reagents and Lateral Flow Readers Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Lateral Flow Assays
by Product - Percentage Breakdown of Value Revenues for Kits &
Reagents and Lateral Flow Readers for the Years 2012, 2020 &
2027

Table 91: Germany Current & Future Analysis for Lateral Flow
Assays by Application - Clinical Testing, Veterinary
Diagnostics and Other Applications - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: Germany Historic Review for Lateral Flow Assays by
Application - Clinical Testing, Veterinary Diagnostics and
Other Applications Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Lateral Flow Assays
by Application - Percentage Breakdown of Value Revenues for
Clinical Testing, Veterinary Diagnostics and Other Applications
for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Lateral Flow
Assays by End-Use - Hospitals & Clinics, Diagnostic
Laboratories, Pharma & Biotech Companies and Other End-Uses -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Lateral Flow Assays by
End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma &
Biotech Companies and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Lateral Flow Assays
by End-Use - Percentage Breakdown of Value Revenues for
Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech
Companies and Other End-Uses for the Years 2012, 2020 & 2027

ITALY
Table 97: Italy Current & Future Analysis for Lateral Flow
Assays by Product - Kits & Reagents and Lateral Flow Readers -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Lateral Flow Assays by
Product - Kits & Reagents and Lateral Flow Readers Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Lateral Flow Assays by_x000D
Read the full report: https://www.reportlinker.com/p06097736/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting